PANK2
Basic information
Region (hg38): 20:3888839-3929887
Previous symbols: [ "C20orf48", "NBIA1" ]
Links
Phenotypes
GenCC
Source:
- pantothenate kinase-associated neurodegeneration (Strong), mode of inheritance: AR
- hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (Definitive), mode of inheritance: AR
- pantothenate kinase-associated neurodegeneration (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration; Neurodegeneration with brain iron accumulation 1 | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Gastrointestinal; Hematologic; Neurologic; Ophthalmologic | 477009; 7158329; 3969211; 1447570; 1734303; 7885538; 7898702; 8944032; 11479594; 12058097; 12510040; 14638969; 15911822; 15642932; 16240131; 16437574; 16687521; 18981035; 20301663; 21286947 |
ClinVar
This is a list of variants' phenotypes submitted to
- Pigmentary pallidal degeneration (58 variants)
- not provided (9 variants)
- Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (4 variants)
- Retinitis pigmentosa (2 variants)
- Neurodegeneration (2 variants)
- Inborn genetic diseases (2 variants)
- Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration;Pigmentary pallidal degeneration (1 variants)
- PANK2-related disorder (1 variants)
- Dystonic disorder (1 variants)
- Pigmentary pallidal degeneration;Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (1 variants)
- Cone-rod dystrophy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PANK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 193 | 195 | ||||
missense | 14 | 21 | 172 | 217 | ||
nonsense | 11 | 18 | ||||
start loss | 1 | |||||
frameshift | 29 | 37 | ||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 11 | |||||
splice region | 1 | 1 | 4 | 14 | 1 | 21 |
non coding | 17 | 84 | 23 | 128 | ||
Total | 62 | 40 | 199 | 287 | 25 |
Highest pathogenic variant AF is 0.000217
Variants in PANK2
This is a list of pathogenic ClinVar variants found in the PANK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-3888963-G-A | Likely benign (Sep 11, 2018) | |||
20-3889048-G-A | Likely benign (Jul 26, 2019) | |||
20-3889079-G-C | Likely benign (Sep 26, 2018) | |||
20-3889090-G-A | not specified • Pigmentary pallidal degeneration | Benign/Likely benign (Sep 05, 2018) | ||
20-3889097-G-T | PANK2-related disorder | Likely benign (Mar 12, 2019) | ||
20-3889107-A-C | Pigmentary pallidal degeneration | Likely benign (May 22, 2023) | ||
20-3889109-G-A | Pigmentary pallidal degeneration | Likely benign (Dec 09, 2023) | ||
20-3889109-G-T | Pigmentary pallidal degeneration • Inborn genetic diseases | Uncertain significance (Jun 28, 2022) | ||
20-3889112-C-G | Pigmentary pallidal degeneration | Likely benign (Sep 26, 2023) | ||
20-3889112-C-T | Pigmentary pallidal degeneration | Conflicting classifications of pathogenicity (May 01, 2023) | ||
20-3889114-G-A | Pigmentary pallidal degeneration | Uncertain significance (Apr 04, 2022) | ||
20-3889118-C-T | Pigmentary pallidal degeneration | Likely benign (Aug 02, 2023) | ||
20-3889124-C-T | Pigmentary pallidal degeneration | Likely benign (Oct 22, 2023) | ||
20-3889130-C-T | Pigmentary pallidal degeneration • PANK2-related disorder | Likely benign (Oct 15, 2023) | ||
20-3889131-G-A | Pigmentary pallidal degeneration | Uncertain significance (Jun 03, 2022) | ||
20-3889134-C-T | Pigmentary pallidal degeneration • not specified • Inborn genetic diseases | Conflicting classifications of pathogenicity (Feb 08, 2024) | ||
20-3889136-TTGGGCGGCGCCGCCATCACTCTCTTC-T | Pigmentary pallidal degeneration | Conflicting classifications of pathogenicity (Aug 23, 2022) | ||
20-3889137-T-C | Pigmentary pallidal degeneration • Inborn genetic diseases | Uncertain significance (Feb 28, 2023) | ||
20-3889138-G-A | Pigmentary pallidal degeneration | Uncertain significance (Aug 09, 2022) | ||
20-3889142-G-A | Pigmentary pallidal degeneration | Likely benign (Jul 16, 2023) | ||
20-3889145-G-A | Pigmentary pallidal degeneration | Likely benign (Sep 18, 2023) | ||
20-3889148-G-A | Pigmentary pallidal degeneration | Likely benign (Nov 10, 2023) | ||
20-3889154-A-G | Pigmentary pallidal degeneration | Conflicting classifications of pathogenicity (Dec 12, 2023) | ||
20-3889155-C-T | Pigmentary pallidal degeneration | Uncertain significance (Mar 11, 2021) | ||
20-3889158-T-C | Pigmentary pallidal degeneration | Uncertain significance (May 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PANK2 | protein_coding | protein_coding | ENST00000316562 | 7 | 38120 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.40e-7 | 0.909 | 125698 | 0 | 50 | 125748 | 0.000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.179 | 298 | 307 | 0.971 | 0.0000165 | 3576 |
Missense in Polyphen | 50 | 88.235 | 0.56667 | 1021 | ||
Synonymous | -2.36 | 163 | 129 | 1.26 | 0.00000696 | 1224 |
Loss of Function | 1.68 | 13 | 21.4 | 0.608 | 0.00000111 | 261 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000380 | 0.000380 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000248 | 0.000246 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.000163 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be the master regulator of the CoA biosynthesis. {ECO:0000250}.;
- Disease
- DISEASE: Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (HARP) [MIM:607236]: Rare syndrome with many clinical similarities to PKAN. {ECO:0000269|PubMed:12058097}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Pantothenate and CoA biosynthesis - Homo sapiens (human);Coenzyme A biosynthesis;Vitamin B5 - CoA biosynthesis from pantothenate;Metabolism;Vitamin B5 (pantothenate) metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;coenzyme A biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.192
Intolerance Scores
- loftool
- 0.132
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 37.11
Haploinsufficiency Scores
- pHI
- 0.461
- hipred
- N
- hipred_score
- 0.446
- ghis
- 0.594
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.994
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pank2
- Phenotype
- renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- pank2
- Affected structure
- nucleate erythrocyte
- Phenotype tag
- abnormal
- Phenotype quality
- spatial pattern
Gene ontology
- Biological process
- spermatid development;aerobic respiration;coenzyme biosynthetic process;coenzyme A biosynthetic process;pantothenate metabolic process;phosphorylation;regulation of fatty acid metabolic process;regulation of mitochondrial membrane potential;mitochondrion morphogenesis;regulation of triglyceride metabolic process;regulation of bile acid metabolic process
- Cellular component
- nucleus;mitochondrion;mitochondrial intermembrane space;cytosol
- Molecular function
- pantothenate kinase activity;ATP binding